First Report of Dramatic Tumor Responses with Ramucirumab and Paclitaxel After Progression on Pembrolizumab in Two Cases of Metastatic Gastroesophageal Adenocarcinoma.

First Report of Dramatic Tumor Responses with Ramucirumab and Paclitaxel After Progression on Pembrolizumab in Two Cases of Metastatic Gastroesophageal Adenocarcinoma. — المؤلف: Chakrabarti, Sakti — The oncologist 20190920

المؤلف
Chakrabarti, Sakti
النشر
The oncologist 20190920
الوصف
840-843 p.
الموضوعات
Adenocarcinoma؛ Antibodies, Monoclonal؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Combined Chemotherapy Protocols؛ Disease Progression؛ Esophageal Neoplasms؛ Female؛ Humans